172 related articles for article (PubMed ID: 26250458)
21. High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer.
Hawsawi O; Henderson V; Burton LJ; Dougan J; Nagappan P; Odero-Marah V
Biochem Biophys Res Commun; 2018 Sep; 504(1):196-202. PubMed ID: 30177390
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition.
Yang H; Liang J; Zhou J; Mi J; Ma K; Fan Y; Ning J; Wang C; Wei X; Li E
Mol Med Rep; 2016 Jun; 13(6):5255-61. PubMed ID: 27108649
[TBL] [Abstract][Full Text] [Related]
23. HMGA2 promotes the migration and invasion of gallbladder cancer cells and HMGA2 knockdown inhibits angiogenesis via targeting VEGFA.
Yan J; Dai P; Qin X; He Y; Zhang Y
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913073
[TBL] [Abstract][Full Text] [Related]
24. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
25. Suppression of HER-2 via siRNA interference promotes apoptosis and decreases metastatic potential of SKOV‑3 human ovarian carcinoma cells.
Lu YM; Rong ML; Shang C; Wang N; Li X; Zhao YY; Zhang SL
Oncol Rep; 2013 Mar; 29(3):1133-9. PubMed ID: 23292493
[TBL] [Abstract][Full Text] [Related]
26. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
27. Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells.
Park GB; Chung YH; Kim D
Oncol Rep; 2017 May; 37(5):3137-3145. PubMed ID: 28350104
[TBL] [Abstract][Full Text] [Related]
28. Effects of HMGA2 gene downregulation by siRNA on lung carcinoma cell migration in A549 cell lines.
Naghizadeh S; Mansoori B; Mohammadi A; Kafil HS; Mousavi Z; Sakhinia E; Baradaran B
J Cell Biochem; 2019 Apr; 120(4):5024-5032. PubMed ID: 30317663
[TBL] [Abstract][Full Text] [Related]
29. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D
Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of ARK5 expression suppresses invasion of ovarian cancer cells.
Wang S; Li S; Wang H; Li W; Gao Y; Wang X; Fang C; Zhang B; Sun X; Li R; Shi W; Chen M; Shi L
Mol Med Rep; 2019 Apr; 19(4):2927-2934. PubMed ID: 30720082
[TBL] [Abstract][Full Text] [Related]
31. Adipose-derived mesenchymal stem cells promote cell proliferation and invasion of epithelial ovarian cancer.
Chu Y; Tang H; Guo Y; Guo J; Huang B; Fang F; Cai J; Wang Z
Exp Cell Res; 2015 Sep; 337(1):16-27. PubMed ID: 26209607
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
Cai J; Shen G; Liu S; Meng Q
Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
[TBL] [Abstract][Full Text] [Related]
33. siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.
Esmailzadeh S; Mansoori B; Mohammadi A; Shanehbandi D; Baradaran B
J Gastrointest Cancer; 2017 Jun; 48(2):156-163. PubMed ID: 27629422
[TBL] [Abstract][Full Text] [Related]
34. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
35. STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer.
Wu J; Lai M; Shao C; Wang J; Wei JJ
Oncol Rep; 2015 Sep; 34(3):1494-502. PubMed ID: 26165228
[TBL] [Abstract][Full Text] [Related]
36. Gonadotropins promote human ovarian cancer cell migration and invasion via a cyclooxygenase 2-dependent pathway.
Feng D; Zhao T; Yan K; Liang H; Liang J; Zhou Y; Zhao W; Ling B
Oncol Rep; 2017 Aug; 38(2):1091-1098. PubMed ID: 28677781
[TBL] [Abstract][Full Text] [Related]
37. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
38. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
[TBL] [Abstract][Full Text] [Related]
39. Effects of HMGA2 on the epithelial-mesenchymal transition-related genes in ACHN renal cell carcinoma cells-derived xenografts in nude mice.
Liu Y; Lv G; Bai J; Song L; Ding E; Liu L; Tian Y; Chen Q; Li K; Liu X; Ding Y
BMC Cancer; 2022 Apr; 22(1):421. PubMed ID: 35439951
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
